Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is a publicly traded Healthcare sector company. As of September 2, 2026, MIRM trades at $99.81 with a market cap of $6.00B and a P/E ratio of -7.04. MIRM moved +1.48% today. Year to date, MIRM is +27.87%; over the trailing twelve months it is +33.80%. Its 52-week range spans $36.88 to $130.00. Analyst consensus is strong buy with an average price target of $135.10. Rallies surfaces MIRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MIRM insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $99.81 |
| Market Cap | $6.00B |
| P/E Ratio | -7.04 |
| EPS | $-14.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.00 |
| 52-Week Low | $36.88 |
| Volume | 361.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $618.07M |
| Net Income | $-860.21M |
| Gross Margin | 0.00% |
10 analysts cover MIRM: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $135.10.